Iron and folate deficiency conditions are one the most common conditions, both among gynecological patients of reproductive age and in pregnant women.
Low levels of folate and iron can lead to several diseases including pregnancy complications, fetal malformations, and delayed mental development of the neonate.
A recent Russian study confirms that the right combination of these components, active folate and iron, can make up for basic micronutrient deficiencies in women of reproductive age. Clinical and laboratory efficacy (the absence of objective anemia signs and the changes in hemoglobin level, folate and ferritin blood tests over time), as well as tolerability (the rate of adverse events, tolerability of the taken product evaluated using the visual analog scale) was assessed at days 30, 60 and 90 after the beginning of treatment.
The result confirms maintaining iron and active folate, such as Quatrefolic®, homeostasis by oral intake during three months in the preconception period and early stages of pregnancy is a feasible option based on its high efficacy and good tolerability with the minimal risk of side effects.